Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-016977
Filing Date
2025-06-27
Accepted
2025-06-27 17:30:11
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm S-1/A 875858
2 EX-5.1 ex5-1.htm EX-5.1 17222
3 EX-23.1 ex23-1.htm EX-23.1 2496
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 56862
5 GRAPHIC forms-1a_001.jpg GRAPHIC 11557
6 GRAPHIC ex5-1_001.jpg GRAPHIC 15653
  Complete submission text file 0001641172-25-016977.txt   1125557

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 8170
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-287963 | Film No.: 251088086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)